| pubmed-article:16822820 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16822820 | lifeskim:mentions | umls-concept:C1516231 | lld:lifeskim |
| pubmed-article:16822820 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16822820 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:16822820 | lifeskim:mentions | umls-concept:C0085183 | lld:lifeskim |
| pubmed-article:16822820 | lifeskim:mentions | umls-concept:C0037663 | lld:lifeskim |
| pubmed-article:16822820 | lifeskim:mentions | umls-concept:C0278704 | lld:lifeskim |
| pubmed-article:16822820 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:16822820 | pubmed:dateCreated | 2006-9-8 | lld:pubmed |
| pubmed-article:16822820 | pubmed:abstractText | GH deficiency is common in childhood cancer survivors. In a previous report, although we did not find an increase in the risk of disease recurrence in survivors treated with GH, GH-treated survivors did have an increased risk of developing a second neoplasm (SN) (rate ratio, 3.21). | lld:pubmed |
| pubmed-article:16822820 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16822820 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16822820 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16822820 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16822820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16822820 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16822820 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:16822820 | pubmed:issn | 0021-972X | lld:pubmed |
| pubmed-article:16822820 | pubmed:author | pubmed-author:QinJingJ | lld:pubmed |
| pubmed-article:16822820 | pubmed:author | pubmed-author:YasuiYutakaY | lld:pubmed |
| pubmed-article:16822820 | pubmed:author | pubmed-author:HellerGlennG | lld:pubmed |
| pubmed-article:16822820 | pubmed:author | pubmed-author:SklarCharles... | lld:pubmed |
| pubmed-article:16822820 | pubmed:author | pubmed-author:RobisonLeslie... | lld:pubmed |
| pubmed-article:16822820 | pubmed:author | pubmed-author:MertensAnn... | lld:pubmed |
| pubmed-article:16822820 | pubmed:author | pubmed-author:MitbyPaulineP | lld:pubmed |
| pubmed-article:16822820 | pubmed:author | pubmed-author:ShiWeijiW | lld:pubmed |
| pubmed-article:16822820 | pubmed:author | pubmed-author:Ergun-Longmir... | lld:pubmed |
| pubmed-article:16822820 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16822820 | pubmed:volume | 91 | lld:pubmed |
| pubmed-article:16822820 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16822820 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16822820 | pubmed:pagination | 3494-8 | lld:pubmed |
| pubmed-article:16822820 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:meshHeading | pubmed-meshheading:16822820... | lld:pubmed |
| pubmed-article:16822820 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16822820 | pubmed:articleTitle | Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. | lld:pubmed |
| pubmed-article:16822820 | pubmed:affiliation | Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York, 10021, USA. | lld:pubmed |
| pubmed-article:16822820 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16822820 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16822820 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:16822820 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16822820 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16822820 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16822820 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16822820 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16822820 | lld:pubmed |
